TNF and inflammatory bowel disease: Multiple studies have proposed different biological variables (such as anti-TNF-α, anti-integrins, or anti-ILs) and small molecules (such as tofacitinib, a non-selective Janus kinase (JAK) inhibitor) as potential candidates for treating IBD.